IMM 18.6% 35.0¢ immutep limited

cvac patients posting trial progress, page-13

  1. 1,251 Posts.
    lightbulb Created with Sketch. 713
    Yes Westhx I listened to the presentation last week.

    To be honest I found it entirely underwhelming. Mainly because it seemed clear that there would not be an update for Overall Survival (OS) from Can-003 until the end of the year.

    Which tends to knock the wind out of the sails of the idea that the ASCO presentation was going to announce any new news. Which was based on the notion that the second remission data would mature more quickly than the first remission data and PRR might consider splitting this out in an update. Given that this is the whole basis on which Can-004(2) is built.

    On the positive there should be some news about “first” patient started to Can-004(2) shortly.

    I’m not sure who the audience is for these types of presentations but imo the sales pitch from ML is terrible. According to ML Can-003 produced a compelling signal that suggests Can-004(2) will be a big success.

    This is absurd. The signal from Can-003 stopped a P3 trial in its track and halved the share price. Now it only takes the newest of investors about 2 minutes to pull up a chart to see the sp going off a cliff late last year for the harder questions to be asked.

    Perhaps for the completely computer illiterate older wealthy investor, with no understanding of the sector, the sales pitch might be perfect.

    So fundamentally it looks pretty shot. Which makes the strength in the sp currently a little bit surprising. Many other bio stocks are really taking a hammering – and why hasn’t PRR dropped 20% in line with general sentiment.

    I would like to think it is due to the strength of the register but I’m not so sure. Volumes are so low reflecting little interest.

    I kind of get the feeling that a buy now has the potential to make you look like a genius or put you in the dunces corner.

    For me a buy now would not really be on the basis of the hope that PRR or ML may be able to think up a better story for all of this. I just don't think they are up to it.

    But I do think there is a good possibility that someone will decide on another pump and dump. The timing of which is unpredictable. Hence it boils down to how much loose change you can afford tied up going nowhere for goodness knows how long. But with ultimately a pretty good return if you have the patience.

    GLTH Southoz
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
0.055(18.6%)
Mkt cap ! $504.7M
Open High Low Value Volume
36.0¢ 37.5¢ 33.5¢ $5.658M 15.86M

Buyers (Bids)

No. Vol. Price($)
18 396332 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 125903 4
View Market Depth
Last trade - 15.09pm 12/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.